EFM
E Fund Management Portfolio holdings
AUM
$2.1B
1-Year Return
23.31%
This Quarter Return
+6.51%
1 Year Return
+23.31%
3 Year Return
+155.42%
5 Year Return
–
10 Year Return
–
AUM
$1.95B
AUM Growth
+$137M
(+7.6%)
Cap. Flow
+$70.7M
Cap. Flow
% of AUM
3.63%
Top 10 Holdings %
Top 10 Hldgs %
62.7%
Holding
375
New
57
Increased
197
Reduced
86
Closed
22
Top Buys
| 1 |
Apple
AAPL
|
$12.2M |
| 2 |
Microsoft
MSFT
|
$12.2M |
| 3 |
NVIDIA
NVDA
|
$9.41M |
| 4 |
Broadcom
AVGO
|
$6.49M |
| 5 |
Pinduoduo
PDD
|
$5.98M |
Top Sells
| 1 |
ASE Group
ASX
|
$18.3M |
| 2 |
Sea Limited
SE
|
$11.3M |
| 3 |
TSMC
TSM
|
$9.44M |
| 4 |
ZTO Express
ZTO
|
$7.08M |
| 5 |
NIO
NIO
|
$4.53M |
Sector Composition
| 1 | Consumer Discretionary | 37.74% |
| 2 | Technology | 30.94% |
| 3 | Communication Services | 8.5% |
| 4 | Healthcare | 6.31% |
| 5 | Financials | 5.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Goldman Sachs
GS
$223B
| $225K | 0.01% |
454
-30
| -6% | -$14.9K |
|
302
Progressive
PGR
$143B
| $225K | 0.01% |
+885
| New | +$225K |
|
303
Vera Therapeutics
VERA
$1.54B
| $224K | 0.01% |
5,073
-2,322
| -31% | -$103K |
|
304
Gen Digital
GEN
$18.2B
| $224K | 0.01% |
+8,170
| New | +$224K |
|
305
Trimble
TRMB
$19.2B
| $224K | 0.01% |
+3,601
| New | +$224K |
|
306
Arrowhead Research
ARWR
$4.02B
| $222K | 0.01% |
11,438
+2,538
| +29% | +$49.2K |
|
307
Enphase Energy
ENPH
$5.18B
| $220K | 0.01% |
+1,949
| New | +$220K |
|
308
Denali Therapeutics
DNLI
$2.26B
| $220K | 0.01% |
7,561
-1,639
| -18% | -$47.7K |
|
309
Zimmer Biomet
ZBH
$20.9B
| $218K | 0.01% |
2,022
+105
| +5% | +$11.3K |
|
310
Akamai
AKAM
$11.3B
| $218K | 0.01% |
+2,158
| New | +$218K |
|
311
Align Technology
ALGN
$10.1B
| $217K | 0.01% |
+855
| New | +$217K |
|
312
Rhythm Pharmaceuticals
RYTM
$6.78B
| $217K | 0.01% |
+4,149
| New | +$217K |
|
313
Steris
STE
$24.2B
| $217K | 0.01% |
893
-46
| -5% | -$11.2K |
|
314
West Pharmaceutical
WST
$18B
| $215K | 0.01% |
717
+83
| +13% | +$24.9K |
|
315
Cardinal Health
CAH
$35.7B
| $215K | 0.01% |
1,942
-112
| -5% | -$12.4K |
|
316
Mirum Pharmaceuticals
MIRM
$3.82B
| $214K | 0.01% |
+5,491
| New | +$214K |
|
317
Warner Bros
WBD
$30B
| $213K | 0.01% |
25,869
+1,928
| +8% | +$15.9K |
|
318
United Rentals
URI
$62.7B
| $212K | 0.01% |
+262
| New | +$212K |
|
319
Syndax Pharmaceuticals
SNDX
$1.47B
| $212K | 0.01% |
11,020
+214
| +2% | +$4.12K |
|
320
Cooper Companies
COO
$13.5B
| $211K | 0.01% |
+1,913
| New | +$211K |
|
321
Quest Diagnostics
DGX
$20.5B
| $211K | 0.01% |
+1,359
| New | +$211K |
|
322
Revvity
RVTY
$10.1B
| $210K | 0.01% |
+1,645
| New | +$210K |
|
323
Bio-Techne
TECH
$8.46B
| $210K | 0.01% |
+2,628
| New | +$210K |
|
324
Labcorp
LH
$23.2B
| $210K | 0.01% |
+939
| New | +$210K |
|
325
Hologic
HOLX
$14.8B
| $208K | 0.01% |
2,558
-157
| -6% | -$12.8K |
|